Circulation, Vol 89, 1580-1586, Copyright © 1994 by American Heart Association
CM Wei, A Lerman, RJ Rodeheffer, CG McGregor, RR Brandt, S Wright, DM Heublein, PC Kao, WD Edwards and JC Burnett Jr
BACKGROUND: Although recent investigations report the elevation of plasma
endothelin (ET) in congestive heart failure (CHF), it remains unclear if
this elevation is that of the biologically active peptide ET- 1 or of its
precursor big-ET. Furthermore, it is unclear if such elevation is
associated with increased myocardial ET and if the molecular form from
cardiac tissue is altered ET. Last, it remains to be established whether
circulating ET is increased at the earliest stage of CHF in patients with
asymptomatic left ventricular dysfunction and correlates with the magnitude
of ventricular dysfunction. METHODS AND RESULTS: The present study was
designed to investigate concentrations and molecular forms of ET in plasma
and cardiac tissue in healthy subjects and CHF patients with New York Heart
Association (NYHA) class I through IV using cardiac radionuclide angiogram,
cardiac myocardial biopsy, radioimmunoassay, gel permeation chromatography
(GPC), and immunohistochemical staining (IHCS). Plasma ET was increased
only in patients with moderate (NYHA class III) or severe (NYHA class IV)
CHF compared with healthy subjects and individuals with asymptomatic (NYHA
class I) or mild (NYHA class II) CHF. The elevation of circulating ET in
CHF showed a negative correlation with left ventricular ejection fraction
and cardiac index and a positive correlation with functional class and left
ventricular end-diastolic volume index. GPC demonstrated that
immunoreactive plasma ET was ET-1 in healthy subjects and both mature ET-1
and its precursor big-ET in severe CHF patients, with big-ET the
predominant molecular form. Cardiac tissue concentrations and IHCS revealed
ET presence in healthy atrial and ventricular tissue, which were not
different in severe CHF. GPC revealed that the molecular form of cardiac ET
was ET-1 in both healthy and CHF hearts. CONCLUSIONS: The present study
establishes for the first time that the elevation of plasma ET in severe
human CHF represents principally elevation of big-ET. Second, ET is present
in healthy and failing myocardia, and its activity by both
immunohistochemistry and radioimmunoassay is not changed in CHF.
Furthermore, the elevated plasma ET is characteristic of severe CHF and not
asymptomatic or mild CHF. In addition, the degree of plasma elevation of ET
correlates with the magnitude of alterations in cardiac hemodynamics and
functional class. The present study confirms and extends previous
investigations of ET in human CHF and establishes the evolution of
circulating and local cardiac ET in the spectrum of human CHF.
ARTICLES
Endothelin in human congestive heart failure
Cardiorenal Research Laboratory, Mayo Clinic and Foundation, Rochester, MN 55905.
This article has been cited by other articles:
 |
|
 |
|
  S. Bansal, J. Lindenfeld, and R. W. Schrier Sodium Retention in Heart Failure and Cirrhosis: Potential Role of Natriuretic Doses of Mineralocorticoid Antagonist? Circ Heart Fail, July 1, 2009; 2(4): 370 - 376. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Dixon and F. G. Spinale Large Animal Models of Heart Failure: A Critical Link in the Translation of Basic Science to Clinical Practice Circ Heart Fail, May 1, 2009; 2(3): 262 - 271. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Hilal-Dandan, H. He, J. L. Martin, L. L. Brunton, and W. H. Dillmann Endothelin downregulates SERCA2 gene and protein expression in adult rat ventricular myocytes: regulation by pertussis toxin-sensitive Gi protein and cAMP Am J Physiol Heart Circ Physiol, March 1, 2009; 296(3): H728 - H734. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. V. G. Edwards, M. Y. White, and S. J. Cordwell The Role of Proteomics in Clinical Cardiovascular Biomarker Discovery Mol. Cell. Proteomics, October 1, 2008; 7(10): 1824 - 1837. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. L. Domeier, A. V. Zima, J. T. Maxwell, S. Huke, G. A. Mignery, and L. A. Blatter IP3 receptor-dependent Ca2+ release modulates excitation-contraction coupling in rabbit ventricular myocytes Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H596 - H604. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G.-W. He, M.-H. Liu, Q. Yang, A. Furnary, and A. P.C. Yim Role of Endothelin-1 Receptor Antagonists in Vasoconstriction Mediated by Endothelin and Other Vasoconstrictors in Human Internal Mammary Artery Ann. Thorac. Surg., November 1, 2007; 84(5): 1522 - 1527. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Bredin, A. Olsson, and A. Franco-Cereceda No Additive Effect of Passive Containment Surgery in Patients With Aortic Regurgitation and Left Ventricular Dilation Ann. Thorac. Surg., August 1, 2007; 84(2): 510 - 513. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P.J. Halcox, K. R.A. Nour, G. Zalos, and A. A. Quyyumi Endogenous Endothelin in Human Coronary Vascular Function: Differential Contribution of Endothelin Receptor Types A and B Hypertension, May 1, 2007; 49(5): 1134 - 1141. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. R. Schwarz, S. Rastogi, V. Kapur, N. Sulemanjee, and J. J. Rodriguez Erectile Dysfunction in Heart Failure Patients J. Am. Coll. Cardiol., September 19, 2006; 48(6): 1111 - 1119. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Xydas, A. R. Kherani, J. S. Chang, S. Klotz, I. Hay, C. J. Mutrie, G. W. Moss, A. Gu, A. R. Schulman, D. Gao, et al. beta2-Adrenergic Stimulation Attenuates Left Ventricular Remodeling, Decreases Apoptosis, and Improves Calcium Homeostasis in a Rodent Model of Ischemic Cardiomyopathy J. Pharmacol. Exp. Ther., May 1, 2006; 317(2): 553 - 561. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Gomez-Garre, M. Herraiz, M. L. Gonzalez-Rubio, R. Bernal, P. Aragoncillo, A. Carbonell, J. J. Rufilanchas, and A. Fernandez-Cruz Activation of peroxisome proliferator-activated receptor-{alpha} and -{gamma} in auricular tissue from heart failure patients Eur J Heart Fail, March 1, 2006; 8(2): 154 - 161. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. van der Velden, N. A. Narolska, R. R. Lamberts, N. M. Boontje, A. Borbely, R. Zaremba, J. G.F. Bronzwaer, Z. Papp, K. Jaquet, W. J. Paulus, et al. Functional effects of protein kinase C-mediated myofilament phosphorylation in human myocardium Cardiovasc Res, March 1, 2006; 69(4): 876 - 887. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S J Leslie, J C S Spratt, S P McKee, F E Strachan, D E Newby, D B Northridge, M A Denvir, and D J Webb Direct comparison of selective endothelin A and non-selective endothelin A/B receptor blockade in chronic heart failure Heart, July 1, 2005; 91(7): 914 - 919. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kruger, J. Graf, D. Kunz, T. Stickel, M. W. Merx, P. Hanrath, and U. Janssens Urotensin II in patients with chronic heart failure Eur J Heart Fail, June 1, 2005; 7(4): 475 - 478. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kupari, T. S. Mikkola, H. Turto, and J. Lommi Is the pregnancy hormone relaxin an important player in human heart failure? Eur J Heart Fail, March 2, 2005; 7(2): 195 - 198. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Cowburn, J. G.F. Cleland, T. A. McDonagh, J. D. McArthur, H. J. Dargie, and J. J. Morton Comparison of selective ETA and ETB receptor antagonists in patients with chronic heart failure Eur J Heart Fail, January 1, 2005; 7(1): 37 - 42. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.J. Raboisson, J.C. Fouron, J. Lamoureux, L. Leduc, A. Grignon, F. Proulx, and S. Gamache Early Intertwin Differences in Myocardial Performance During the Twin-to-Twin Transfusion Syndrome Circulation, November 9, 2004; 110(19): 3043 - 3048. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Gao, C. Wei, L. Chen, J. Huang, S. Yang, and A. M. Diehl Oxidative DNA damage and DNA repair enzyme expression are inversely related in murine models of fatty liver disease Am J Physiol Gastrointest Liver Physiol, November 1, 2004; 287(5): G1070 - G1077. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. G von Lueder, H. Kjekshus, T. Edvardsen, E. Oie, S. Urheim, L. E. Vinge, M. S. Ahmed, O. A Smiseth, and H. Attramadal Mechanisms of elevated plasma endothelin-1 in CHF: congestion increases pulmonary synthesis and secretion of endothelin-1 Cardiovasc Res, July 1, 2004; 63(1): 41 - 50. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Latini, S. Masson, I. Anand, M. Salio, A. Hester, D. Judd, S. Barlera, A. P Maggioni, G. Tognoni, J. N Cohn, et al. The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFT Eur. Heart J., February 2, 2004; 25(4): 292 - 299. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-C. Chen, C.-J. Wu, H.-K. Yip, H.-W. Chang, C.-J. Chen, T.-H. Yu, and W. C. Hung Increased Circulating Endothelin-1 in Rheumatic Mitral Stenosis: Irrelevance to Left Atrial and Pulmonary Artery Pressures Chest, February 1, 2004; 125(2): 390 - 396. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Konstam and D. DeNofrio Endothelin Expression and the Progression of Heart Failure: Exemplifying the Vagaries of Therapeutic Development Circulation, January 20, 2004; 109(2): 143 - 145. [Full Text] [PDF]
|
|
|
|
|
|
J. A. Schirger, H. H. Chen, M. Jougasaki, O. Lisy, G. Boerrigter, A. Cataliotti, and J. C. Burnett Jr Endothelin A Receptor Antagonism in Experimental Congestive Heart Failure Results in Augmentation of the Renin-Angiotensin System and Sustained Sodium Retention Circulation, January 20, 2004; 109(2): 249 - 254. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Modesti, S. Vanni, I. Bertolozzi, I. Cecioni, C. Lumachi, A. M. Perna, M. Boddi, and G. F. Gensini Different Growth Factor Activation in the Right and Left Ventricles in Experimental Volume Overload Hypertension, January 1, 2004; 43(1): 101 - 108. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. D. Wagner, S. Buz, C. Knosalla, R. Hetzer, and B. Hocher Modulation of Circulating Endothelin-1 and Big Endothelin by Nitric Oxide Inhalation Following Left Ventricular Assist Device Implantation Circulation, September 9, 2003; 108(90101): II-278 - 284. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Torre-Amione, J. B. Young, W. S. Colucci, B. S. Lewis, C. Pratt, G. Cotter, K. Stangl, U. Elkayam, J. R. Teerlink, A. Frey, et al. Hemodynamic and clinical effects of tezosentan, an intravenous dual endothelin receptor antagonist, in patients hospitalized for acute decompensated heart failure J. Am. Coll. Cardiol., July 2, 2003; 42(1): 140 - 147. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. W Kenyon and J. M Nappi Bosentan for the Treatment of Pulmonary Arterial Hypertension Ann. Pharmacother., July 1, 2003; 37(7): 1055 - 1062. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Chu, R. Takahashi, I. Norota, T. Miyamoto, Y. Takeishi, K. Ishii, I. Kubota, and M. Endoh Signal Transduction and Ca2+ Signaling in Contractile Regulation Induced by Crosstalk Between Endothelin-1 and Norepinephrine in Dog Ventricular Myocardium Circ. Res., May 16, 2003; 92(9): 1024 - 1032. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. O'Connor, W. A. Gattis, K. F. Adams Jr, V. Hasselblad, B. Chandler, A. Frey, I. Kobrin, M. Rainisio, M. R. Shah, J. Teerlink, et al. Tezosentan in patients with acuteheart failure and acute coronary syndromes: Results of the randomized intravenous tezosentan study (ritz-4) J. Am. Coll. Cardiol., May 7, 2003; 41(9): 1452 - 1457. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Ogata, M. Takahashi, S. Ueno, K. Takeuchi, T. Okada, H. Mano, S. Ookawara, K. Ozawa, B. C. Berk, U. Ikeda, et al. Antiapoptotic Effect of Endothelin-1 in Rat Cardiomyocytes In Vitro Hypertension, May 1, 2003; 41(5): 1156 - 1163. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. F. Leite-Moreira, C. Bras-Silva, C. A. Pedrosa, and A. A. Rocha-Sousa ET-1 increases distensibility of acutely loaded myocardium: a novel ETA and Na+/H+ exchanger-mediated effect Am J Physiol Heart Circ Physiol, April 1, 2003; 284(4): H1332 - H1339. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T-L Wang and C-R Hung Enhanced endothelin-1 degradation by intravenous morphine in patients with congestive heart failure: role of neutral endopeptidase 24.11 Heart, February 1, 2003; 89(2): 211 - 212. [Full Text] [PDF]
|
|
|
|
|
|
E. Kaluski, I. Kobrin, R. Zimlichman, A. Marmor, O. Krakov, O. Milo, A. Frey, S. Kaplan, R. Krakover, A. Caspi, et al. RITZ-5: randomized intravenousTeZosentan (an endothelin-A/B antagonist)for the treatment of pulmonary edema: A prospective, multicenter, double-blind, placebo-controlled study J. Am. Coll. Cardiol., January 15, 2003; 41(2): 204 - 210. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. P. Rossi, C. Ganzaroli, M. Cesari, A. Maresca, M. Plebani, G. G. Nussdorfer, and A. C. Pessina Endothelin receptor blockade lowers plasma aldosterone levels via different mechanisms in primary aldosteronism and high-to-normal renin hypertension Cardiovasc Res, January 1, 2003; 57(1): 277 - 283. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Piuhola, I. Szokodi, P. Kinnunen, M. Ilves, R. deChatel, O. Vuolteenaho, and H. Ruskoaho Endothelin-1 Contributes to the Frank-Starling Response in Hypertrophic Rat Hearts Hypertension, January 1, 2003; 41(1): 93 - 98. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Baba, T. Yoshikawa, and S. Ogawa Autoantibodies produced against sarcolemmal Na-K-ATPase: possible upstream targets of arrhythmias and sudden death in patients with dilated cardiomyopathy J. Am. Coll. Cardiol., September 18, 2002; 40(6): 1153 - 1159. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. P. Bolger, R. Sharma, W. Li, M. Leenarts, P. R. Kalra, M. Kemp, A. J.S. Coats, S. D. Anker, and M. A. Gatzoulis Neurohormonal Activation and the Chronic Heart Failure Syndrome in Adults With Congenital Heart Disease Circulation, July 2, 2002; 106(1): 92 - 99. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A. El-Solh, E. Bozkanat, J. Mador, and B. J. B. Grant Association Between Plasma Endothelin-1 Levels and Cheyne-Stokes Respiration in Patients With Congestive Heart Failure* Chest, June 1, 2002; 121(6): 1928 - 1934. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R Sharma and S.D Anker From tissue wasting to cachexia: changes in peripheral blood flow and skeletal musculature Eur. Heart J. Suppl., April 1, 2002; 4(suppl_D): D12 - D17. [Abstract] [PDF]
|
|
|
|
|
|
T. Tsuruda, M. Jougasaki, G. Boerrigter, B. K. Huntley, H. H. Chen, A. B. D'Assoro, S. C. Lee, A. M. Larsen, A. Cataliotti, and J. C. Burnett Jr Cardiotrophin-1 Stimulation of Cardiac Fibroblast Growth: Roles for Glycoprotein 130/Leukemia Inhibitory Factor Receptor and the Endothelin Type A Receptor Circ. Res., February 8, 2002; 90(2): 128 - 134. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Hurlimann, F. Ruschitzka, and T.F. Luscher The relationship between the endothelium and the vessel wall Eur. Heart J. Suppl., February 1, 2002; 4(suppl_A): A1 - A7. [Abstract] [PDF]
|
|
|
|
|
|
P.J. Cowburn and J.G.F. Cleland Endothelin antagonists for chronic heart failure: do they have a role? Eur. Heart J., October 1, 2001; 22(19): 1772 - 1784. [PDF]
|
|
|
|
 |
|
 T. DSCHIETZIG, C. RICHTER, C. BARTSCH, M. LAULE, F. P. ARMBRUSTER, G. BAUMANN, and K. STANGL The pregnancy hormone relaxin is a player in human heart failure FASEB J, October 1, 2001; 15(12): 2187 - 2195. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Luchner, F. Muders, O. Dietl, E. Friedrich, F. Blumberg, A.A. Protter, G.A.J. Riegger, and D. Elsner Differential expression of cardiac ANP and BNP in a rabbit model of progressive left ventricular dysfunction Cardiovasc Res, August 15, 2001; 51(3): 601 - 607. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Aleksic, Z. Szabo, U. Scheffel, H. T. Ravert, W. B. Mathews, L. Kerenyi, P. A. Rauseo, R. E. Gibson, H. D. Burns, and R. F. Dannals In Vivo Labeling of Endothelin Receptors with [11C]L-753,037: Studies in Mice and a Dog J. Nucl. Med., August 1, 2001; 42(8): 1274 - 1280. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Boixel, S. Dinanian, L. Lang-Lazdunski, J.-J. Mercadier, and S. N. Hatem Characterization of effects of endothelin-1 on the L-type Ca2+ current in human atrial myocytes Am J Physiol Heart Circ Physiol, August 1, 2001; 281(2): H764 - H773. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Iwanaga, Y. Kihara, K. Inagaki, Y. Onozawa, T. Yoneda, K. Kataoka, and S. Sasayama Differential Effects of Angiotensin II Versus Endothelin-1 Inhibitions in Hypertrophic Left Ventricular Myocardium During Transition to Heart Failure Circulation, July 31, 2001; 104(5): 606 - 612. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. E. Spieker, G. Noll, F. T. Ruschitzka, and T. F. Luscher Endothelin receptor antagonists in congestive heart failure: a new therapeutic principle for the future? J. Am. Coll. Cardiol., May 1, 2001; 37(6): 1493 - 1505. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-P. Cheng, T. Ukai, K. Onishi, N. Ohte, M. Suzuki, Z.-S. Zhang, H.-J. Cheng, H. Tachibana, A. Igawa, and W. C. Little The role of ANG II and endothelin-1 in exercise-induced diastolic dysfunction in heart failure Am J Physiol Heart Circ Physiol, April 1, 2001; 280(4): H1853 - H1860. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R Weir and Chiming Wei The role of angiotensin II and TGF-beta on the progression of chronic allograft nephropathy Journal of Renin-Angiotensin-Aldosterone System, March 1, 2001; 2(1_suppl): S188 - S190. [Abstract] [PDF]
|
|
|
|
|
|
F. Duru, M. Barton, T. F. Luscher, and R. Candinas Endothelin and cardiac arrhythmias: do endothelin antagonists have a therapeutic potential as antiarrhythmic drugs? Cardiovasc Res, February 1, 2001; 49(2): 272 - 280. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Lepailleur-Enouf, G. Egidy, M. Philippe, L. Louedec, J.-P. Henry, P. Mulder, and J.-B. Michel Pulmonary endothelinergic system in experimental congestive heart failure Cardiovasc Res, February 1, 2001; 49(2): 330 - 339. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Chiming Wei, M. G Cardarelli, S. W Downing, and J. S McLaughlin The effect of angiotensin II on mitogen-activated protein kinase in human cardiomyocytes Journal of Renin-Angiotensin-Aldosterone System, December 1, 2000; 1(4): 379 - 384. [Abstract] [PDF]
|
|
|
|
 |
|
 G. N. Onuoha, E. K. Alpar, and J. Gowar Endothelin-1 Levels in Severe Burn Injuries Arch Surg, December 1, 2000; 135(12): 1418 - 1421. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Walker, S. C. Baicu, A. T. Goldberg, C. E. Widener, D. J. Fary, D. K. Almany, A. Ergul, F. A. Crawford Jr, and F. G. Spinale Temporal endothelin dynamics of the myocardial interstitium and systemic circulation in cardiopulmonary bypass J. Thorac. Cardiovasc. Surg., November 1, 2000; 120(5): 864 - 871. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-T. Shen, P. S Buie, J. J Lynch, S. M Krause, and X.-L. Ma Chronic therapy with an ETA/B receptor antagonist in conscious dogs during progression of congestive heart failure: Intracellular Ca2+ regulation and nitric oxide mediated coronary relaxation Cardiovasc Res, November 1, 2000; 48(2): 332 - 345. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Araki, K. Hasegawa, E. Iwai-Kanai, M. Fujita, T. Sawamura, T. Kakita, H. Wada, T. Morimoto, and S. Sasayama Endothelin-1 as a protective factor against beta-adrenergic agonist-induced apoptosis in cardiac myocytes J. Am. Coll. Cardiol., October 1, 2000; 36(4): 1411 - 1418. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Stangl, T. Dschietzig, C. Richter, M. Laule, V. Stangl, E. Tanis, G. Baumann, and S. B. Felix Pulmonary Release and Coronary and Peripheral Consumption of Big Endothelin and Endothelin-1 in Severe Heart Failure : Acute Effects of Vasodilator Therapy Circulation, September 5, 2000; 102(10): 1132 - 1138. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Luchner, M. Jougasaki, E. Friedrich, D. D. Borgeson, T. L. Stevens, M. M. Redfield, G. A. J. Riegger, and J. C. Burnett Jr. Activation of cardiorenal and pulmonary tissue endothelin-1 in experimental heart failure Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2000; 279(3): R974 - R979. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. AMANN, K. MÜNTER, S. WESSELS, J. WAGNER, V. BALAJEW, S. HERGENRÖDER, G. MALL, and E. RITZ Endothelin A Receptor Blockade Prevents Capillary/Myocyte Mismatch in the Heart of Uremic Animals J. Am. Soc. Nephrol., September 1, 2000; 11(9): 1702 - 1711. [Abstract] [Full Text]
|
|
|
|
|
|
J. Bauersachs, D. Fraccarollo, P. Galuppo, J. Widder, and G. Ertl Endothelin-receptor blockade improves endothelial vasomotor dysfunction in heart failure Cardiovasc Res, July 1, 2000; 47(1): 142 - 149. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P Love, C. J Ferro, W. G Haynes, C. Plumpton, A. P Davenport, D. J Webb, and J. J.V McMurray Endothelin receptor antagonism in patients with chronic heart failure Cardiovasc Res, July 1, 2000; 47(1): 166 - 172. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Zolk and M. Bohm The role of the cardiac endothelin system in heart failure Nephrol. Dial. Transplant., June 1, 2000; 15(6): 758 - 760. [Full Text] [PDF]
|
|
|
|
|
|
M. J. Clair, M. K. King, A. T. Goldberg, J. W. Hendrick, R. Nisato, D. M. Gay, A. E. Morrison, J. H. McElmurray III, R. S. Krombach, B. R. Bond, et al. Selective Vasopressin, Angiotensin II, or Dual Receptor Blockade with Developing Congestive Heart Failure J. Pharmacol. Exp. Ther., June 1, 2000; 293(3): 852 - 860. [Abstract] [Full Text]
|
|
|
|
|
|
A. Ergul, C. A. Walker, A. Goldberg, S. C. Baicu, J. W. Hendrick, M. K. King, and F. G. Spinale ET-1 in the myocardial interstitium: relation to myocyte ECE activity and expression Am J Physiol Heart Circ Physiol, June 1, 2000; 278(6): H2050 - H2056. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Kjekshus, O. A. Smiseth, R. Klinge, E. Oie, M. E. Hystad, and H. Attramadal Regulation of ET: pulmonary release of ET contributes to increased plasma ET levels and vasoconstriction in CHF Am J Physiol Heart Circ Physiol, April 1, 2000; 278(4): H1299 - H1310. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. G. N. Serneri, I. Cecioni, S. Vanni, R. Paniccia, B. Bandinelli, A. Vetere, X. Janming, I. Bertolozzi, M. Boddi, G. F. Lisi, et al. Selective Upregulation of Cardiac Endothelin System in Patients With Ischemic but Not Idiopathic Dilated Cardiomyopathy : Endothelin-1 System in the Human Failing Heart Circ. Res., March 3, 2000; 86(4): 377 - 385. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. T. Rademaker, V. A. Cameron, C. J. Charles, E. A. Espiner, M. G. Nicholls, C. J. Pemberton, and A. M. Richards Neurohormones in an ovine model of compensated postinfarction left ventricular dysfunction Am J Physiol Heart Circ Physiol, March 1, 2000; 278(3): H731 - H740. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. MacCarthy, R. Grocott-Mason, B. D. Prendergast, and A. M. Shah Contrasting Inotropic Effects of Endogenous Endothelin in the Normal and Failing Human Heart : Studies With an Intracoronary ETA Receptor Antagonist Circulation, January 18, 2000; 101(2): 142 - 147. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Mishima, M. Tanimura, G. Suzuki, A. Todor, V. G. Sharov, S. Goldstein, and H. N. Sabbah Effects of long-term therapy with bosentan on the progression of left ventricular dysfunction and remodeling in dogs with heart failure J. Am. Coll. Cardiol., January 1, 2000; 35(1): 222 - 229. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. E. Negrao, M. A. Hamilton, G. C. Fonarow, A. Hage, J. D. Moriguchi, and H. R. Middlekauff Impaired endothelium-mediated vasodilation is not the principal cause of vasoconstriction in heart failure Am J Physiol Heart Circ Physiol, January 1, 2000; 278(1): H168 - H174. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Wei and J. C. Burnett Jr. Inhibition by calcium antagonism of circulating and renal endothelin in experimental congestive heart failure Am J Physiol Heart Circ Physiol, January 1, 2000; 278(1): H263 - H268. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Ono, A. Matsumori, T. Shioi, Y. Furukawa, and S. Sasayama Contribution of Endothelin-1 to Myocardial Injury in a Murine Model of Myocarditis : Acute Effects of Bosentan, an Endothelin Receptor Antagonist Circulation, October 26, 1999; 100(17): 1823 - 1829. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Bajoria, M. Sullivan, and N. M. Fisk Endothelin concentrations in monochorionic twins with severe twin–twin transfusion syndrome Hum. Reprod., June 1, 1999; 14(6): 1614 - 1618. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Tiret, O. Poirier, V. Hallet, T. A. McDonagh, C. Morrison, J. J. V. McMurray, H. J. Dargie, D. Arveiler, J.-B. Ruidavets, G. Luc, et al. The Lys198Asn Polymorphism in the Endothelin-1 Gene Is Associated With Blood Pressure in Overweight People Hypertension, May 1, 1999; 33(5): 1169 - 1174. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Zolk, J. Quattek, G. Sitzler, T. Schrader, G. Nickenig, P. Schnabel, K. Shimada, M. Takahashi, and M. Bohm Expression of Endothelin-1, Endothelin-Converting Enzyme, and Endothelin Receptors in Chronic Heart Failure Circulation, April 27, 1999; 99(16): 2118 - 2123. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Pieske, B. Beyermann, V. Breu, B. M. Loffler, K. Schlotthauer, L. S. Maier, S. Schmidt-Schweda, H. Just, and G. Hasenfuss Functional Effects of Endothelin and Regulation of Endothelin Receptors in Isolated Human Nonfailing and Failing Myocardium Circulation, April 13, 1999; 99(14): 1802 - 1809. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Parker, J. J. Thiessen, R. Reilly, J. H. Tong, D. J. Stewart, and A. S. Pandey Human Endothelin-1 Clearance Kinetics Revealed by a Radiotracer Technique J. Pharmacol. Exp. Ther., April 1, 1999; 289(1): 261 - 265. [Abstract] [Full Text]
|
|
|
|
|
|
P. J. Cowburn, J. G. F. Cleland, J. D. McArthur, M. R. MacLean, J. J. V. McMurray, H. J. Dargie, and J. J. Morton EndothelinB receptors are functionally important in mediating vasoconstriction in the systemic circulation in patients with left ventricular systolic dysfunction J. Am. Coll. Cardiol., March 15, 1999; 33(4): 932 - 938. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Onishi, M. Ohno, W. C. Little, and C.-P. Cheng Endogenous Endothelin-1 Depresses Left Ventricular Systolic and Diastolic Performance in Congestive Heart Failure J. Pharmacol. Exp. Ther., March 1, 1999; 288(3): 1214 - 1222. [Abstract] [Full Text]
|
|
|
|
|
|
T. Inada, H. Fujiwara, K. Hasegawa, M. Araki, R. Yamauchi-Kohno, H. Yabana, T. Fujiwara, M. Tanaka, and S. Sasayama Upregulated expression of cardiac endothelin-1 participates in myocardial cell growth in Bio14.6 Syrian cardiomyopathic hamsters J. Am. Coll. Cardiol., February 1, 1999; 33(2): 565 - 571. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kaburagi, K. Hasegawa, T. Morimoto, M. Araki, T. Sawamura, T. Masaki, and S. Sasayama The Role of Endothelin-Converting Enzyme-1 in the Development of {alpha}1-Adrenergic-Stimulated Hypertrophy in Cultured Neonatal Rat Cardiac Myocytes Circulation, January 19, 1999; 99(2): 292 - 298. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Anwaar, A. Gottsater, F. Lindgarde, and I. Mattiasson Increasing Plasma Neopterin and Persistent Plasma Endothelin During Follow-up After Acute Cerebral Ischemia Angiology, January 1, 1999; 50(1): 1 - 8. [Abstract] [PDF]
|
|
|
|
|
|
G. Sutsch, W. Kiowski, X.-W. Yan, P. Hunziker, S. Christen, W. Strobel, J.-H. Kim, P. Rickenbacher, and O. Bertel Short-Term Oral Endothelin-Receptor Antagonist Therapy in Conventionally Treated Patients With Symptomatic Severe Chronic Heart Failure Circulation, November 24, 1998; 98(21): 2262 - 2268. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Hulsmann, B. Stanek, B. Frey, B. Sturm, D. Putz, T. Kos, R. Berger, W. Woloszczuk, G. Maurer, and R. Pacher Value of cardiopulmonary exercise testing and big endothelin plasma levels to predict short-term prognosis of patients with chronic heart failure J. Am. Coll. Cardiol., November 15, 1998; 32(6): 1695 - 1700. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Alexiou, T. Dschietzig, O. Simsch, M. Laule, J. Hundertmark, G. Baumann, and K. Stangl Arrhythmogenic effects induced by coronary conversion of pulmonary big endothelin to endothelin: Aggravation of this phenomenon in heritable hyperlipidemia J. Am. Coll. Cardiol., November 15, 1998; 32(6): 1773 - 1778. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Saad, R. Mukherjee, P. B. Thomas, J. P. Iannini, C. G. Basler, L. Hebbar, S.-J. O, S. Moreland, M. L. Webb, J. R. Powell, et al. The effects of endothelin-A receptor blockade during the progression of pacing-induced congestive heart failure J. Am. Coll. Cardiol., November 15, 1998; 32(6): 1779 - 1786. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Iwanaga, Y. Kihara, K. Hasegawa, K. Inagaki, T. Yoneda, S. Kaburagi, M. Araki, and S. Sasayama Cardiac Endothelin-1 Plays a Critical Role in the Functional Deterioration of Left Ventricles During the Transition From Compensatory Hypertrophy to Congestive Heart Failure in Salt-Sensitive Hypertensive Rats Circulation, November 10, 1998; 98(19): 2065 - 2073. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. G. Spinale, R. Mukherjee, R. S. Krombach, M. J. Clair, J. W. Hendrick, W. V. Houck, L. Hebbar, S. B. Kribbs, J. L. Zellner, and M. G. Dodd Chronic Amlodipine Treatment During the Development of Heart Failure Circulation, October 20, 1998; 98(16): 1666 - 1674. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Dupuis, J.-L. Rouleau, and P. Cernacek Reduced Pulmonary Clearance of Endothelin-1 Contributes to the Increase of Circulating Levels in Heart Failure Secondary to Myocardial Infarction Circulation, October 20, 1998; 98(16): 1684 - 1687. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. W. Mays, T. Ripple, M. T. Eginton, G. R. Seabrook, R. A. Cambria, J. B. Towne, and J. A. Freischlag Smoking Cessation Reverses Arterial Endothelium-Dependent Relaxation Injury Vascular and Endovascular Surgery, September 1, 1998; 32(5): 407 - 413. [Abstract] [PDF]
|
|
|
|
|
|
P. J. Cowburn, J. G.F. Cleland, J. D. McArthur, M. R. MacLean, H. J. Dargie, J. J.V. McMurray, and J. J. Morton Endothelin-1 has haemodynamic effects at pathophysiological concentrations in patients with left ventricular dysfunction Cardiovasc Res, September 1, 1998; 39(3): 563 - 570. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. W Moe, A. Albernaz, G. O Naik, M. Kirchengast, and D. J Stewart Beneficial effects of long-term selective endothelin type A receptor blockade in canine experimental heart failure Cardiovasc Res, September 1, 1998; 39(3): 571 - 579. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Choussat, L. Hittinger, F. Barbe, G. Maistre, A. Carayon, B. Crozatier, and J. Su Acute effects of an endothelin-1 receptor antagonist bosentan at different stages of heart failure in conscious dogs Cardiovasc Res, September 1, 1998; 39(3): 580 - 588. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Suzuki, N. Ohte, Z.-M. Wang, D. L. Williams Jr., W. C. Little, and C.-P. Cheng Altered inotropic response of endothelin-1 in cardiomyocytes from rats with isoproterenol-induced cardiomyopathy Cardiovasc Res, September 1, 1998; 39(3): 589 - 599. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Mulder, V. Richard, F. Bouchart, G. Derumeaux, K. Munter, and C. Thuillez Selective ETA receptor blockade prevents left ventricular remodeling and deterioration of cardiac function in experimental heart failure Cardiovasc Res, September 1, 1998; 39(3): 600 - 608. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S M Maguire, A G Nugent, C McGurk, G D Johnston, and D P Nicholls Abnormal vascular responses in human chronic cardiac failure are both endothelium dependent and endothelium independent Heart, August 1, 1998; 80(2): 141 - 145. [Abstract] [Full Text]
|
|
|
|
|
|
R.S. Krombach, M. J Clair, J. W Hendrick, W. V Houck, J. L Zellner, S. B Kribbs, S. Whitebread, R. Mukherjee, M. de Gasparo, and F. G Spinale Angiotensin converting enzyme inhibition, AT1 receptor inhibition, and combination therapy with pacing induced heart failure: effects on left ventricular performance and regional blood flow patterns Cardiovasc Res, June 1, 1998; 38(3): 631 - 645. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Bozkurt, S. B. Kribbs, F. J. Clubb Jr, L. H. Michael, V. V. Didenko, P. J. Hornsby, Y. Seta, H. Oral, F. G. Spinale, and D. L. Mann Pathophysiologically Relevant Concentrations of Tumor Necrosis Factor-{alpha} Promote Progressive Left Ventricular Dysfunction and Remodeling in Rats Circulation, April 14, 1998; 97(14): 1382 - 1391. [Abstract] [Full Text] [PDF]
|
|